News | News By Subject | News by Disease News By Date | Search News

Vaccine News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Massachusetts' Agenus (AGEN) Quietly Discloses Failure of Cancer Vaccine Trial     2/22/2017
The 7 Worst Clinical Disasters of 2016     12/27/2016
FDA Slaps Partial Hold on Bay Area Firm Aduro Biotech (ADRO)'s Cancer Vaccine Trial     10/25/2016
Anthrax Vaccine Maker Emergent BioSolutions (EBS) Lays Off 91 in Michigan     10/6/2016
Novavax (NVAX) Stayin' Alive After Shares Crater on Flunked Phase III     9/19/2016
Vaxart Challenges Takeda (TKPYY) with Oral Norovirus Vaccine     8/8/2016
Altimmune Receives BARDA Contract Of Up To $120.2 Million To Fund Clinical Development Of First-In-Class Anthrax Vaccine Candidate Nasoshield     8/2/2016
FDA Clears Expanded Approval of Pfizer (PFE)'s Best-Selling Pneumonia Vaccine     7/13/2016
Galena Biopharma  (GALE) Craters and Discontinues Phase III Breast Cancer Vaccine NeuVax     6/30/2016
Vaxart Pins Hopes on Oral Zika and Flu Virus Vaccines     3/25/2016
Valneva Snags $42 Million IXIARO Supply Contract with US Government     3/16/2016
Celldex (CLDX) Stock Chokes as Brain Cancer Trial Halted     3/8/2016
Sanofi (SNY) and Merck & Co. (MRK) to Dismantle Joint Vaccines Venture After 22 Years     3/8/2016
Analysts Take a Peek at Pfizer (PFE)'s 2015 Drug Sales, With a Few Surprises     12/31/2015
Engineered mRNA Company Moderna Launches 4th Spinoff, Caperna     10/22/2015

News from Around the Web
Above The Rise Of Merck & Co. (MRK)’s Gardasil Vaccine, A Specter Is Looming     2/3/2017
Bill Gates Is Teaming Up With World Leaders To Stop The Next Deadly Pandemic     1/20/2017
5 Facts Donald Trump Needs To Know About Vaccines     1/11/2017
Philippine FDA Orders Sanofi (SNY) To Take Down Dengue Vaccine Ads     1/5/2017
An Experimental Zika Vaccine Is Being Tested In Humans — And Bill Gates Is Picking Up The Tab     12/5/2016
Gutsy Anti-Vaccine Activists Spot An Ally In The Oval Office     11/30/2016
Flu Vaccine During Pregnancy Not Linked To Autism, Published In JAMA     11/29/2016
Couple Accuses Merck & Co. (MRK) Of Failing To Disclose Zostavax Vaccine Side Effects     11/18/2016
Here Are 3 Ways To Play The Growing Market For Vaccines Right Now     11/11/2016
The $5.8 Billion Hidden Cost Of The Flu On The U.S. Economy     10/31/2016
63 Japanese Women Sue the Government, GlaxoSmithKline (GSK) and Merck & Co. (MRK) Over HPV Vaccines     10/24/2016
UNICEF Clinches Vaccine Deal To Protect Children From Five Diseases     10/19/2016
Cure For Herpes "On The Horizon," Rational Vaccines Reveals     10/19/2016
Why Doctors Without Borders Is Turning Down A Million Free Pneumonia Vaccines From Pfizer (PFE)     10/12/2016
3 Biotech Investing Lessons From Novavax (NVAX)'s Huge Vaccine Flop     10/7/2016

Press Releases
The World's Richest Doctor's New Cancer Vaccine and NantKwest's Science     2/23/2017
VBI Vaccines Receives Positive Response From Health Canada’s Initial Evaluation Of The Proposed Sci-B-Vac Phase III Clinical Program     2/22/2017
Trianni Signs Agreement With Stanford University For Use Of The Trianni Mouse In Vaccine Research     2/22/2017
hVIVO Services Limited Notes The Initiation Of A Phase I Clinical Trial With AGS-V, A Mosquito-Borne Disease Vaccine Candidate     2/21/2017
CEL-SCI (CVM) Scientist Presents New Findings For Rheumatoid Arthritis Treatment Vaccine At Conference     2/21/2017
University of Pennsylvania School of Medicine Team Tracks Rare T Cells In Blood To Better Understand Annual Flu Vaccine     2/21/2017
Sanaria Inc.'s PfSPZ-CVac Vaccine Achieves High Level Protection Against Malaria In Clinical Trial     2/16/2017
Vaxart Announces Positive Phase I Study Of Oral Norovirus Vaccine     2/14/2017
Allergy Therapeutics Announces Novel House Dust Mite Allergy Vaccine Gains Clinical Trial Application Approval     2/14/2017
Expanded Vaccine Offering For PharmaJet Needle-free Device     2/14/2017
VBI Vaccines Receives Positive EMA Scientific Advice Regarding Sci-B-Vac Phase III Clinical Study     2/7/2017
TapImmune (TPIV) Expands Intellectual Property On PolyStart Platform For Use In Next-Generation T-Cell Vaccines     2/7/2017
Findings Published In Nature Show The Potential Of A Messenger RNA Vaccine To Protect Against Zika Virus     2/3/2017
TapImmune (TPIV) Completes Scale-Up And GMP Manufacturing Of TPIV 200 Vaccine To Supply Additional Phase 2 Clinical Trials     2/2/2017
Sanofi Pasteur (SASY.PA) Announces The Availability of Quadracel DTaP-IPV Vaccine For Children 4 Through 6 Years Of Age In The U.S.     1/31/2017

//-->